OF
MAREKETING
MANAGEMENT
Topic:- REVLON
SKIN CLINIC
Marketing Strategy
• Marketing research
• Organisatonal structure and plan
• Fianancial projections
INTRODUCTION
Revlon Inc. was founded in 1932 by Charles Revson, Joseph Revson and
Charles Lachmann. The Company began with only one product – nail
enamel. Revlon Inc. later introduced other numerous products such as
fragrances, manicure and pedicure instruments, and other cosmetic
products. Within six years, Revlon Inc. turned into a multimillion dollar
organization, becoming one of the most recognized cosmetics names in
the world. Revlon Inc. is now one of the world's leaders in cosmetics,
skin care, fragrance and personal care. Their vision is to "provide
glamour, excitement and innovation through quality products at
affordable prices."
Revlon Incorporated
Revlon, Inc., through its direct wholly owned operating subsidiary, Revlon
Consumer Products Corporation manufactures, markets and sells an array of
cosmetics, women’s hair color, beauty tools, fragrances, skincare, anti-
perspirants/deodorants and personal care products. The Company’s products
are sold worldwide and marketed as Revlon, which includes the Revlon
ColorStay, Revlon Super Lustrous and Revlon Age Defying franchises, as
well as the Almay brand, which includes the Almay Intense i-Color and Almay
Smart Shade franchises, in cosmetics; Revlon ColorSilk in women’s hair color;
Revlon in beauty tools, Charlie and Jean Nate in fragrances, Ultima II and
Gatineau in skincare, and Mitchum in personal care products. The Company’s
principal customers include retailers, chain drug stores and food stores, as
well as certain department stores and other specialty stores, such as
perfumeries, outside the United States. The Company also sells beauty
products to United States military exchanges and commissaries.
Age: 57 yrs
Tagline
Business Mission
COMPANY DESCRIPTION
Revlon Inc. reported unaudited consolidated earnings results for the third quarter and
nine months ended September 30, 2009. For the third quarter, the company reported
net sales of $326.2 million compared to $334.4 million, a decrease of 2.5% over the
same period a year ago. Operating income was $50.3 million compared to $19.8
million a year ago. Income from continuing operations was $23.1 million, or $0.45
per diluted share, compared to a loss from continuing operations of $15.2 million, or
$0.30 per diluted share. The improvement in income from continuing operations was
driven primarily by improved operating income of $30.5 million. Net income was
$23.1 million, or $0.45 per diluted share, compared to $29.2 million, or $0.57 per
diluted share, which included income from discontinued operations of $44.4 million,
or $0.87 per diluted share. Adjusted EBITDA in the third quarter of 2009 was $66.5
million compared to $42.6 million in the same period last year. Operating income,
income from continuing operations, net income, and adjusted EBITDA in the third
quarter of 2009 included $2.6 million, or $0.05 per diluted share, of charges related to
the restructuring actions announced on May 28, 2009. Free cash flow in the third
quarter of 2009 was $54.1 million compared to free cash flow of $16.9 million in the
same period last year, primarily driven by improved income from continuing
operations and continued improvement in working capital efficiency. Income from
continuing operations before income taxes was $25.6 million against loss from
continuing operations before income taxes of $12.8 million for the same period a year
ago. Net sales for the first nine months of 2009 decreased 6.1% to $951.3 million,
compared to net sales of $1,012.6 million in the first nine months of 2008. Excluding
unfavorable foreign currency fluctuations of $42.8 million, net sales decreased by
1.8%. Operating income was $108.5 million in the first nine months of 2009, which
included $21.4 million of restructuring charges and other, compared to $111.0 million
in the first nine months of 2008. Adjusted EBITDA was $158.6 million in the first
nine months of 2009, which included $21.4 million of restructuring charges and other,
compared to $181.4 million in the same period last year. Income from continuing
operations in the first nine months of 2009 was $35.7 million, or $0.69 per diluted
share, which included $21.4 million, or $0.42 per diluted share, of restructuring
charges and other, compared to $1.9 million, or $0.04 per diluted share, in the same
period last year. Net income in the first nine months of 2009 was $36.0 million, or
$0.70 per fully diluted share, which included $21.4 million, or $0.42 per diluted share,
of restructuring charges, compared to $46.6 million or $0.91 per share in the first nine
months of 2008. Net income in the first nine months of 2008 included income from
discontinued operations of $44.7 million, or $0.87 per diluted share. Income from
continuing operations before income taxes was $36.0 million against $18.7 million for
the same period a year ago. Net cash provided by operating activities was $77.2
million against $43.9 million for the same period a year ago. Capital expenditure for
the period was $10.9 million against $15.1 million for the same period a year ago.
BUSINESS MISSION
MARKETING OBJECTIVE
SITUATION ANALYSIS
Competitors:
SWOT ANALYSIS
Strength
Weakness
Opportunity
Low media spends may make the brand weak over period of
time resulting to death.
Other players
Huge no. of substitutes
MARKETING STRATEGY
TARGET MARKET:
Target market of Revlon for its skin clinic will be the upper
class and the womens of metropolitan cities mainly.
MARKETING MIX
Marketing mix of any company involves 4P’s of the company. These are
as given below:
Product
Price
Place
Promotion
PRODUCT:
This is the very first p of the marketing. For knowing about this, we will
be studing product description, segmentation for revlon’s new skin clinic
and what will be the posioning and product differentiaton.
Product Description:
• Revlon Cream
• Revlon Lotion
• Revlon Moisturizing Makeup
• Revlon Moisturizing Powder
Product Segmentaion:
1. Demographics:
• on the basis of age - 18 to 50 years
• on the basis of sex – women only
• on the basis of income – higher income group
2. Geographics:
• On the basis of social class – upper class
• On the basis of region – metropolitans and big cities
3. Psychographics:
• Lifestyle
• Personality
Product Differentiation:
Products under skin clinic will be different from the competitors under
following ways:
Positoning:
Branding strategy:
The branding strategy for products will be umbrella branding such as:
Revlon Cream
Revlon Lotion
Revlon Moisturizing Makeup
Revlon Moisturizing Powder
PLACE:
This is the second marketing mix and place for the Revlon skin clinic is
as follows:
Distribution channel:
o Manufacturer
o Distributor
o Stockist
o Retailor and salon
PRICING STRATEGY:
Market skimming will be there for all the products under skin
clinic
High quality- high price
High price to target niche market
DISTRIBUTION CHANNEL
REFERENCES
http://www.emporiumonnet.com/beauty_health/revlon/
http://www.emporiumonnet.com/beauty_health/revlon/face_care/
http://www.emporiumonnet.com/beauty_health/revlon/skin_care/
http://www.oppapers.com/essays/Revlon-2004/117446
http://www.euromonitor.com/Revlon_Inc_(Cosmetics_And_Toiletries)
http://www.scribd.com/doc/19481715/Belezza
http://www.cheathouse.com/essay/essay_view.php?p_essay_id=89642
http://www.encyclopedia.com/doc/1G1-10933591.html
http://en.wikipedia.org/wiki/Revlon
http://www.wikinvest.com/stock/Revlon_(REV)
acquire aTING OBJECTIVE
Revlon Inc. reported unaudited consolidated earnings results for the third quarter and
nine months ended September 30, 2009. For the third quarter, the company reported
net sales of $326.2 million compared to $334.4 million, a decrease of 2.5% over the
same period a year ago. Operating income was $50.3 million compared to $19.8
million a year ago. Income from continuing operations was $23.1 million, or $0.45
per diluted share, compared to a loss from continuing operations of $15.2 million, or
$0.30 per diluted share. The improvement in income from continuing operations was
driven primarily by improved operating income of $30.5 million. Net income was
$23.1 million, or $0.45 per diluted share, compared to $29.2 million, or $0.57 per
diluted share, which included income from discontinued operations of $44.4 million,
or $0.87 per diluted share. Adjusted EBITDA in the third quarter of 2009 was $66.5
million compared to $42.6 million in the same period last year. Operating income,
income from continuing operations, net income, and adjusted EBITDA in the third
quarter of 2009 included $2.6 million, or $0.05 per diluted share, of charges related to
the restructuring actions announced on May 28, 2009. Free cash flow in the third
quarter of 2009 was $54.1 million compared to free cash flow of $16.9 million in the
same period last year, primarily driven by improved income from continuing
operations and continued improvement in working capital efficiency. Income from
continuing operations before income taxes was $25.6 million against loss from
continuing operations before income taxes of $12.8 million for the same period a year
ago. Net sales for the first nine months of 2009 decreased 6.1% to $951.3 million,
compared to net sales of $1,012.6 million in the first nine months of 2008. Excluding
unfavorable foreign currency fluctuations of $42.8 million, net sales decreased by
1.8%. Operating income was $108.5 million in the first nine months of 2009, which
included $21.4 million of restructuring charges and other, compared to $111.0 million
in the first nine months of 2008. Adjusted EBITDA was $158.6 million in the first
nine months of 2009, which included $21.4 million of restructuring charges and other,
compared to $181.4 million in the same period last year. Income from continuing
operations in the first nine months of 2009 was $35.7 million, or $0.69 per diluted
share, which included $21.4 million, or $0.42 per diluted share, of restructuring
charges and other, compared to $1.9 million, or $0.04 per diluted share, in the same
period last year. Net income in the first nine months of 2009 was $36.0 million, or
$0.70 per fully diluted share, which included $21.4 million, or $0.42 per diluted share,
of restructuring charges, compared to $46.6 million or $0.91 per share in the first nine
months of 2008. Net income in the first nine months of 2008 included income from
discontinued operations of $44.7 million, or $0.87 per diluted share. Income from
continuing operations before income taxes was $36.0 million against $18.7 million for
the same period a year ago. Net cash provided by operating activities was $77.2
million against $43.9 million for the same period a year ago. Capital expenditure for
the period was $10.9 million against $15.1 million for the same period a year ago.